TUBERCULOSIS SURVEILLENCE KENYA

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Tuberculosis in the UK 2013 report
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
1 TB/HIV Project in the Philippines Yumiko Yanase.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
Utilization of TB control services in Kenya Analysis of wealth inequalities Christy Hanson, PhD, MPH World Health Organization Stop TB Department.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Cases and Rates in 1991 Table 6 Population: ? New SM +: N = 8,507 All Cases: N = 10,903 Table 8 Population: ? New SM +: N = 8,835 All cases: N = 10,872.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
HIV disease in BULAWAYO Photo: WHO 2007 Dr. Paco Trinchán Medical Officer BCC August 2013.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
TB epidemiology in Thailand Philippe Glaziou, on behalf of the epi team Bangkok, August 2013.
Tuberculosis control in Suriname Situational analysis.
TUBERCULOSIS LABORATORY NETWORK - UGANDA Dr. Achilles Katamba Zone TB/Leprosy Supervisor, Kampala City.
Principles and Structure of a Research Protocol Anthony Harries The Union, Paris, France.
Tuberculosis and HIV-AIDS: Achievements with ARV access Dr. Humberto Costa, MD Minister of Health, Brazil.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
TB- HIV Collaborative activities in Romania- may 2006 status
World Tuberculosis Day 2014
Philippe Glaziou Geneva, 12 October 2009
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
MDR-TB Update Dr Kelvin Charambira
Daffodil International University (DIU), Dhaka Bangladesh
TB Control in PHC network and Partners Coordination in Cambodia
PROGRESS IN GLOBAL TB CONTROL
The burden of TB in the Western Pacific
Knowledge gaps in formulating TB Control Policies for Prisons
World Tuberculosis Day 2014
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Global DOTS Expansion: how are we doing?
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
FRANCIS GAUSI and THOMAS NYIRENDA MALAWI.
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
WS on Surveillance & Epidemiology
Success and failure in TB surveillance in Hungary
Review of Wednesday 5th May
Goal Objectives Expected Outcomes
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
National Tuberculosis Control Program Department of Health Philippines Dr. Vivian S. Lofranco Medical Specialist IV.
Cheng shiming National TB Center in China May,3, 2004
TB in South Africa.
National Tuberculosis Control Program in Vietnam
TB epidemiology in Bulgaria
Epidemiology of Tuberculosis in Hong Kong
Dr. Kenneth L. Chebet Director NASCOP/NLTP Division Kenya
PROGRESS IN GLOBAL TB CONTROL
Country Presentation CAMBODIA
Country Presentation on Analysis of Korea
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Communicable Disease Surveillance Centre, London
TB notification in Hong Kong
Issues on the current information system
Country presentation Dr.Vija Riekstina National TB registry
Routine Counselling and HIV testing (CT) for TB patients in Malawi: Rhehab Chimzizi TB-HIV Programme officer National TB Control Programme-Malawi.
Current status – (1) Achievements Building strong political commitment
Presentation transcript:

TUBERCULOSIS SURVEILLENCE KENYA AFRICAN TB SURVEILENCE WORKSHOP, HARARE:ZIMBABWE Presented by: Amos Kutwa Head National Leprosy &Tuberculosis Program Kenya

Outline of the Presentation: Introduction Case finding report Case holding Constraints 12/3/2018 Kutwa2003

Introduction Pop: App 32 million people TB control: MoH/ NGOs/ Private Central unit within NLTP/ NASCOP Division 10 Regional control zones/74 District zones manned by Technical officers TB-ICC since 2002: USAID,CDC,WHO, KNCV, WB,CIDA,KAPTLD 12/3/2018 Kutwa2003

Health units implementing NLTP activities GOK NGO Private Total Hospitals 129 67 15 211 Health Centers 467 53 12 532 Dispensaries 550 73 7 630 Others 8 24 32 1146 201 58 1405 Laboratories 528 150 42 720 AFB microscopy 381 126 35 542 12/3/2018 Kutwa2003

TB Case finding report 2002 TB case finding: 82,114 all types 34,337 PTB + 7-fold increase since early nineties Average annual increase (5 yrs): 16% 50-55% of estimated incidence 40 % HIV + in SM+ (1994) 12/3/2018 Kutwa2003

2002 Notification rates in Kenya 12/3/2018 Kutwa2003

Case Notification Rates Smear positive PTB and all Types TB Kenya 1990-2002 12/3/2018 Kutwa2003

Trend of case detection rates (WHO reports) 12/3/2018 Kutwa2003

Distribution of TB cases by type: 2002 12/3/2018 Kutwa2003

Age -sex Segregation:2002 12/3/2018 Kutwa2003

Trend of Treatment outcomes of New Smear Positive PTB on SCC :1993-2001 12/3/2018 Kutwa2003

SCC Treatment results 2001 cohort Sm.+PTB Sm.-PTB EPTB Relapse Rx success rate 80% 74% 74% 77% Failure rate 0.3% - - 1% Death rate 5% 7% 7% 10% Defaulter rate 9% 12% 10% 7% Transfer 7% 7% 8% 6% 12/3/2018 Kutwa2003

Nomadic Treatment results 2001 cohort Sm.+PTB Sm.-PTB EPTB Relapse Rx success rate 89% 87% 74% 82% Failure rate 1% - - 1% Death rate 4% 6% 6% 12% Defaulter rate 4% 5% 7% 4% Transfer 2% 2% 3% 1% 12/3/2018 Kutwa2003

Constraints to Surveillance Manual data entry at facility/district level Lack of capacity to analyze data at district level Lack of capacity to determine the TB prevalence 12/3/2018 Kutwa2003